1. Genetic tests
  2. CYP2C9*2,*3 genotyping - drug metabolism - Pharmacogenetics

CYP2C9*2,*3 genotyping - drug metabolism - Pharmacogenetics

Genetic test Export to PDF
Full name:
CYP2C9*2,*3 genotyping - drug metabolism - Pharmacogenetics
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Drug Response,
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA
Method category:
Targeted variant analysis
Method technique:
Real-time PCR
Laboratory:
Centre de Génétique Médicale UCL
RIZIV code:
565390-565401
EQA:
  • 2015 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2016 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2017 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2018 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2019 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2020 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2022 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
  • 2023 Molecular genetics group 2-SET A DGKL/RfB-Reference Institute for Bioanalytics
Turnaround time (maximum):
2 weeks
Document(s):
Created:
25 Jul 2019 - 16:39
Changed:
19 Jan 2024 - 11:42